Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1

被引:26
作者
Chang, KS [1 ]
Ohashi, K [1 ]
Onuma, M [1 ]
机构
[1] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Sapporo, Hokkaido 0600818, Japan
关键词
dual luciferase assay; L-meq; Marck's disease virus; meq; transcription activity;
D O I
10.1292/jvms.64.1091
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Meq is one of the candidate oncogenes in the MDV1 genome. We previously reported a difference in the meq open reading frame (ORF) between oncogenic and non-oncogenic MDV1: L-meq. in which a 180-bp sequence is inserted into the meq ORF, is detected in non-oncogenic MDV1. To study the functions of a gene product of L-meq (L-MEQ), transactivation by L-MEQ was analyzed by dual luciferase assay using a reporter gene under the control of long (-1--873 bp) and short (-1--355 bp) meq promoter (LMP and SMP, respectively). LMP showed higher promoter function than SMP. L-MEQ transactivated the expression of the reporter gene, but less than MEQ did. In the presence of SNIP or the cytomegalovirus immediate-early promoter, the same or slightly higher transactivation was observed in cells cotransfected with both meq and L-meq than cells transfected only with meq. However, in the presence of LMP, lower transactivation was observed in cells cotransfected with both meq and L-meq than cells transfected only with meq, suggesting that L-MEQ can be a transrepressor. Replication of a vvMDV1 was enhanced in the cells with meq. Interestingly, however, replication of vvMDV1 was suppressed in the cells with L-meq or with both L-meq and meq, compared to untransfected cells. Thus, L-MEQ could suppress replication of vvMDV1 displaying the meq gene in coinfetced cells.
引用
收藏
页码:1091 / 1095
页数:5
相关论文
共 25 条
[1]   ISOLATION AND CHARACTERIZATION OF A ZINC FINGER POLYPEPTIDE GENE AT THE HUMAN CHROMOSOME-11 WILMS TUMOR LOCUS [J].
CALL, KM ;
GLASER, T ;
ITO, CY ;
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
ROSE, EA ;
KRAL, A ;
YEGER, H ;
LEWIS, WH ;
JONES, C ;
HOUSMAN, DE .
CELL, 1990, 60 (03) :509-520
[2]  
CALNEK BW, 1986, CRC CR REV MICROBIOL, V12, P293
[3]   FURTHER CHARACTERIZATION OF MAREKS-DISEASE VIRUS-INFECTED LYMPHOCYTES .2. INVITRO INFECTION [J].
CALNEK, BW ;
SCHAT, KA ;
ROSS, LJN ;
CHEN, CLH .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (03) :399-406
[4]   FURTHER CHARACTERIZATION OF MAREKS-DISEASE VIRUS-INFECTED LYMPHOCYTES .1. INVIVO INFECTION [J].
CALNEK, BW ;
SCHAT, KA ;
ROSS, LJN ;
SHEK, WR ;
CHEN, CLH .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (03) :389-398
[5]  
FUJIMOTO Y, 1974, JPN J VET RES, V22, P80
[6]   THE STRUCTURE OF MAREK DISEASE VIRUS-DNA - THE PRESENCE OF UNIQUE EXPANSION IN NONPATHOGENIC VIRAL-DNA [J].
FUKUCHI, K ;
TANAKA, A ;
SCHIERMAN, LW ;
WITTER, RL ;
NONOYAMA, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) :751-754
[7]   CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50 [J].
Gwack, Y ;
Byun, H ;
Hwang, S ;
Lim, C ;
Choe, J .
JOURNAL OF VIROLOGY, 2001, 75 (04) :1909-1917
[8]   MAREK DISEASE VIRUS ENCODES A BASIC-LEUCINE ZIPPER GENE RESEMBLING THE FOS/JUN ONCOGENES THAT IS HIGHLY EXPRESSED IN LYMPHOBLASTOID TUMORS [J].
JONES, D ;
LEE, L ;
LIU, JL ;
KUNG, HJ ;
TILLOTSON, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4042-4046
[9]   MAREKS-DISEASE VIRUS [J].
KATO, S ;
HIRAI, K .
ADVANCES IN VIRUS RESEARCH, 1985, 30 :225-277
[10]   Difference in the meq gene between oncogenic and attenuated strains of Marek's disease virus serotype 1 [J].
Lee, SI ;
Takagi, M ;
Ohashi, K ;
Sugimoto, C ;
Onuma, M .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2000, 62 (03) :287-292